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SHORT COMMUNICATION
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The purpose of this study was to characterize changes in
tumor vascular parameters hours after a single radiation
exposure in an orthotopic brain tumor model. U-251 human
brain tumors were established intracerebrally in rat brains,
and tumor blood flow, forward volume transfer constant
(Ktrans) and interstitial volume fraction (ve) were measured
using magnetic resonance imaging (MRI). Tumors were
exposure to a single stereotactic radiation treatment of 20
Gy. Vascular parameters were assessed one additional time
between 2 and 24 h after irradiation. After the second MRI
session, brain tissue histology was examined for gross changes
and apoptosis. In separate studies, cerebral blood flow was
measured in nonimplanted controls before radiation exposure
and 2 and 24 h after 20 Gy irradiation, and in implanted rats
before radiation exposure and at 2 and 24 h after 6 Gy
irradiation. Significant changes were observed in tumor-
bearing rat brains in the hours after 20 Gy irradiation. Two
hours after 20 Gy irradiation, tumor blood flow decreased
nearly 80% and ve decreased by 30%. At 4 h, the Ktrans
increased by 30% over preirradiation values. Extensive
vacuolization and an increase in apoptosis were evident
histologically in rats imaged 2 h after irradiation. Between 8
and 12 h after irradiation, all vascular parameters including
blood flow returned to near preirradiation values. One day
after irradiation, tumor blood flow was elevated 40% over
preirradiation values, and other vascular parameters, includ-
ing Ktrans and ve, were 20–40% below preirradiation values. In
contrast, changes in vascular parameters observed in the
normal brain 2 or 24 h after 20 Gy irradiation were not
significantly different from preirradiation values. Also, tumor
blood flow appeared to be unchanged at 2 h after 6 Gy
irradiation, with a small increase observed at 24 h, unlike the
tumor blood flow changes after 20 Gy irradiation. Large and
significant changes in vascular parameters were observed
hours after 20 Gy irradiation using noninvasive MRI
techniques. It is hypothesized that cellular swelling hours
after a high dose of radiation, coinciding with vacuolization,
led to a decrease in tumor blood flow and ve. Four hours after
radiation exposure, Ktrans increased in concert with an
increase in tumor blood flow. Vascular permeability normal-
ized, 24 h after 20 Gy irradiation, as characterized by a
decrease in Ktrans. Vascular parameters did not change
significantly in the normal brain after 20 Gy irradiation or
in the tumor-bearing brain after 6 Gy irradiation.  2015 by
Radiation Research Society
INTRODUCTION
The use of high-dose radiation therapy (HD-RT), either as
a single exposure, termed stereotactic radiosurgery (SRS) or
multiple treatment sessions, known as hypofractionated
stereotactic radiotherapy (HFSRT), has become an increas-
ingly important treatment option for the management of
brain tumors (1, 2). High-dose radiation therapy provides
anticancer efficacy comparable to other available approach-
es, including surgery and conventional whole brain
irradiation applied in multiple low-dose fractions, is better
tolerated than conventional fractionated radiation therapy
(CF-RT), and allows for better dose conformity, allowing
surgically inaccessible tumors to be treated (1, 3). Although
hypofractionated stereotactic radiotherapy is routinely
delivered to a total dose of 18–30 Gy in 2–5 fractions,
there remains no clear radiobiological rationale to guide the
choice of dose per fraction, and no clinical trial is currently
available to provide guidance on the optimum fraction
number (i.e. 2–5). In fact, the physiology of tumor response
in embedded tumors is not well characterized, and a widely
Editor’s note. The online version of this article (DOI: 10.1667/
RR13458.1) contains supplementary information that is available to
all authorized users.
1 Address for correspondence: Henry Ford Hospital and Wayne
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accepted radiobiological basis for adopting high-dose
radiation therapy has not been established.
One explanation for the positive tumor responses to high-
dose radiation therapy is that tumor vasculature is more
sensitive to it than has been predicted by conventional
radiobiology (4). Unfortunately, there is a paucity of
experimental evidence to support this conjecture, and the
dynamics of vascular physiology in model tumor systems
and surrounding normal tissues in the hours after exposure
to high-dose radiation have not been well studied. In part,
this lack of data is attributable to the laborious process
involved in the techniques that, until recently, have been the
only quantitative means available. In the past, preclinical
studies that examined the effect of tumor blood flow in
response to radiation exposure used techniques that required
death of the animal as part of the measurement, making
repeated measurements in the same animal challenging.
Because of inter-animal variations, sample sizes tended to
become large (on the order of 50), making the determination
of all but the most evident trends difficult to detect.
Recently, noninvasive (thus repeatable) quantitative vascu-
lar measures with variances that allow relatively small
sample sizes (order of 5–10) to detect changes in tumor
vascular physiology have become available (5, 6).
It is important to understand the vascular physiology of
the response to radiation, not only for characterizing
differences between normal and tumor tissues or helping
to determine the influence of vascular changes on tumor
response to radiotherapy, but also because radiation therapy
is often combined with chemotherapeutics based on
delivery via the vasculature. Intriguing observations in
preclinical scientific literature indicate that the optimum
timing of radiation treatment and pharmacologic agents may
be critically dependent on a tumor’s vascular response to
radiation (7). For example, in the animal model employed
herein the optimum sequence and timing of radiation
exposure and the antiangiogenic agent, cilengitide, appears
to be drug first, followed by radiation exposure; an alternate
sequence of drug/radiation is less effective (8). In contrast,
in a related model, when radiation is combined with the
vascular targeting agent, arsenic trioxide, the optimum
sequence and timing appears to be radiation exposure first
followed by pharmacologic agent (9, 10). Currently
available information about the vascular response of tumors
in the hours after radiation exposure is limited. Of particular
note, vascular changes that occur acutely in a tumor after
high-dose radiation exposure are not well characterized.
Herein, the kinetics of vascular parameters are presented in
an orthotopic rat model of human glioma 2–24 h after a 20
Gy single-fraction irradiation and compared with the
response of the normal brain. The results are unexpected,
demonstrating a profound decrease in tumor perfusion,
associated with cell swelling, after a large single dose of
radiation. A similar response is not observed in the normal
brain.
MATERIALS AND METHODS
The studies were conducted in accordance with a protocol approved
by the Henry Ford Hospital Institutional Animal Care and Use
Committee (IACUC). Twenty-five athymic rats (strain code: NIH-
Foxn1rnu; Charles River Laboratories, Wilmington, MA) (;8 weeks
old and 180–200g at time of implant) were implanted with U-251
tumor cells intracerebrally and irradiated as described below. MRI
vascular parameters were measured twice in each animal, with the two
studies separated by approximately 24 h. Figure 1 shows the timing of
the MRI studies and radiation exposure. After the initial MRI,
irradiations were performed at selected time points, 2, 4, 8, 12 or 24 h,
before the second study. Additionally, two control blood flow studies
were performed in: 1. Four rats with normal brains (nontumor
bearing), treated with 20 Gy of radiation; and 2. Two rats with brain
tumors treated with 6 Gy of radiation.
The U-251 Orthotopic Brain Tumor Model
The U-251 orthotopic tumor model derives from a human
glioblastoma. It has been well characterized with respect to tumor
growth and radiation response and constitutes a useful model for
preclinical studies; its phenotype, lacking a strongly invasive
component, resembles that of some metastatic tumors. Athymic rats
were inoculated intracerebrally using previously published methods
(5, 8, 11, 12). Briefly, animals were anesthetized with intramuscular
injections of 80 mg/kg ketamine and 8 mg/kg xylazine. The surgical
zone was swabbed with betadine solution, the eyes coated with Lacri-
Lubet and the head immobilized in a small animal stereotactic device
(David Kopf Instruments, Tujunga, CA). After draping, a 1 cm
incision was made 2 mm right of the midline and the skull was
exposed. A burr hole was drilled 3.5 mm to the right of bregma, taking
care not to penetrate the dura mater. A 10 lL Hamilton syringe with a
26-gauge needle (Model 701; Hamiltont Co., Reno, NV) containing
U-251MG tumor cells freshly harvested from log phase growth [53
105 in 10 ll of phosphate buffered saline (PBS)] was lowered to a
depth of 3.0 mm and then raised back to a depth of 2.5 mm. Cells were
then injected at a rate of 0.5 lL/10 s until the entire volume was
delivered. Tumors implanted in animals following this technique
routinely grow to about 4 mm diameter by 21 days post-implantation.
Around day 21, and then about 24 h later, two MRI studies were
conducted for each animal. Animals were anesthetized with isoflurane
(4% for induction, 0.75–1.5% for maintenance, balance N2O:O2¼ 2:1)
and allowed to spontaneously respire. A tail vein was cannulated for
the administration of the contrast agent. Body temperature was
maintained at 378C with a warm air supply monitored by an intrarectal
type T thermocouple.
FIG. 1. Experimental timeline. The first and second MRI studies
were performed approximately 24 h apart. Each group of animals was
irradiated after the first study and at one of the following time points
before the second MRI: 2, 4, 8, 12 or 24 h.
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Radiation Exposure
Radiation was delivered using a Novalise (BrainLab AG,
Heimstetten, Germany) stereotactic radiosurgery device operating at
6 MV photons. The location of each tumor was determined before
radiation exposure by MRI at the time of the pretreatment blood flow
measurement. At this time, with the rat head positioned horizontally,
the center of the tumor mass was measured relative to the tumor-
implantation drill hole. At the time of irradiation, the stereotactic
coordinates of the tumor-implantation drill hole were used to position
the radiation field over the stereotactic coordinates defining the tumor
center. Rats were anesthetized using intramuscular injections of 80
mg/kg ketamine in the gastrocnemius muscle and 8 mg/kg xylazine in
the contralateral leg. Ten minutes after anesthesia administration, rats
were placed in a stereotactic device with the rat head in the same
orientation as when tumor cells were implanted. A total dose of 20 Gy
was administered at an approximate dose rate of 8 Gy/min using 23 2
cm primary collimation, a 6 mm diameter cone as a secondary
collimator, a source-to-surface distance of 75 cm, a 14 mm bolus
above the skull for electron equilibrium at the tumor depth and a linear
accelerator output rate set at 800 monitor units per min. Tumor
dimensions were covered by the 100% isodose line. The treatment
beam projected in a single anterior-posterior direction from the top of
the skull through the tumor on the right hemisphere exiting under the
jaw. A typical treatment plan is shown in Supplementary Fig. S1
(http://dx.doi.org/10.1667/RR13458.1.S1).
In a control study to investigate blood flow changes, 20 Gy was
delivered to rats without tumors (n¼4). For two of the rats, a 131 cm
field was positioned on the right hemisphere of the skull, bordering the
midline and effectively encompassing half the rat head. The 13 1 cm
field size was included as the start of an investigation of the effect of
radiation volume on vascular parameters (not included in the current
article) and to simplify determination of the radiation field on MRIs.
For the other two rats, the previously described 6 mm cone was used.
In an additional study designed to investigate changes in blood flow in
rat tumors exposed to lower-dose radiation, a single 6 Gy dose was
administered (n ¼ 2). For all studies of tumor-bearing rats, a 6 mm
secondary collimator cone was used. In all additional control studies,
animals were imaged approximately 24 h before irradiation, and 2 and
24 h after irradiation.
MRI Studies
Vascular Parameters
The vascular parameters measured using MRI were: blood flow by
arterial spin labeling (13, 14); dynamic contrast-enhanced (DCE)-MRI
(6, 15) employing a model-selection paradigm in its analysis (6, 16) to
estimate the forward volume transfer constant (Ktrans, a measure of
vascular permeability when blood flow does not limit exchange) of a
contrast agent; contrast agent plasma volume fraction (vp); and the
interstitial volume fraction (ve). All reported vascular measures were
within regions that included on average 6 SEM, 150 6 10 voxels.
On the day before the scheduled irradiation, rats underwent MRI to
determine their suitability for exposure based on their tumor size. If
the maximum extent of their tumor was 3–4 mm, baseline vascular
parameters were collected. If tumors were smaller than 3 mm, rats
were imaged on a subsequent day. If the tumors were too large, the
rats were excluded from further study (and not included in the data
presented). Studies were performed in a 7 Tesla, 20 cm bore system
with a DirectDrive spectrometer and console (Agilent Technologies,
Santa Clara, CA). Gradient maximum strengths and rise times were
250 mT/m and 120 ls. All MRI image sets were acquired with a 323
32 mm2 field of vision.
High-resolution T1-weighted images were acquired pre- and post-
contrast agent with the following parameters: matrix¼ 2563 192, 27
slices, 0.5 mm thickness, no gap, NE ¼ 1, NA ¼ 4, TE/TR ¼ 16/800
ms. A dual-echo three-slice gradient-echo (2GE) MRI sequence was
used for the DCE-MRI study (5, 6). Prior to the 2GE sequence, and
immediately after, two Look-Locker sequences were run so that a
voxel-by-voxel estimate of T1 in the tissue could be made pre- and
post-contrast agent administration. Look-Locker sequence parameters
were as follows: matrix¼1283 64, five 2.0 mm slices, no gap, NE¼
24 inversion-recovery echoes, TR¼ 2,000 ms. The 2GE sequence that
was run between the paired Look-Locker acquisitions had the
following parameters: 150 acquisitions at 4.0 s intervals, matrix ¼
1283 64, three 2.0 mm slices, no gap, tip angle¼ 278, NE¼ 2, NA¼
1, TE¼ 2.0, 4.0 ms, TR¼ 60 ms, SW¼ 150 kHz. The contrast agent
(0.25 mM/kg) (Magnevistt; Bayer Healthcare Pharmaceuticals,
Wayne, NJ) bolus injection was performed by hand push at image
15. Total run time was 10 min.
Spin-echo arterial spin-labeled cerebral blood flow estimates were
acquired in a single central slice, as in previous investigations (14).
MRI parameters were as follows: matrix ¼ 128 3 64, one 2.0 mm
slice, NA ¼ 4, TE/TR¼ 20/1050. Arterial labeling ¼ 1 s, with
alternating gradients and frequency offsets in combinations of 4. Total
time ¼ 18 min. Results are generally reported as percentage changes
from pretreatment values (14, 17).
Histology
Immediately after the final imaging session anesthetized rats were
perfused by cardiac infusion with 4% neutral buffered paraformalde-
hyde and brains removed for histological examination. Paraffin-
embedded tissue sections were processed for H&E staining for gross
examination and TUNEL staining for assessment of the presence of
apoptosis.
Hematoxylin and Eosin Staining
Formalin-fixed, paraffin embedded brain tissue was H&E stained
using previously published techniques (11, 12).
TUNEL Staining
The TUNEL (ApopTagt Plus In Situ Apoptosis Detection Kit;
Millipore, Billerica, MA) method was applied to formalin-fixed,
paraffin embedded brain tissue. After dewaxing and hydration, the
sections were washed in PBS, pH 7.6, for 5 min, then treated with
proteinase K (20 lg/ml) diluted in PBS at room temperature for 15
min and then washed in distilled water for 5 min. TUNEL incubation
solution, comprised of terminal deoxynucleotidyl transferase (TdT)
buffer, cobalt chloride, TdT and biotin-16dUTP, was prepared
according to the manufacture’s protocol. The sections were incubated
in TdT buffer for 1 h at 378C. After incubation, stop solution was
applied to brain sections for 10 min, after which they were washed
twice (5 min) in the PBS. The sections were then incubated with anti-
digoxigenin antibody peroxidase conjugate at room temperature for 30
min. Finally, brain sections were incubated in 3,30-diaminobenzidine
solution for 1 min. The fragmented DNAs were visualized as a
brownish color inside nuclei. The sections were counterstained with
methyl green before being dehydrated and cleared through graded
alcohols and xylenes, and protected with a glass coverslip. Images
were captured using a Nikone DXM1200C camera attached to a
Nikon E00M microscope (Nikon Corp., Tokyo, Japan).
It is estimated that the histological sections corresponding to time
after irradiation of 2, 4, 8, 12 and 24 h are actually 3.5, 5.5, 9.5, 13.5
and 25.5 h after irradiation since the MRI vascular studies took place
about 1.5 h before the animal was euthanized for histology.
Consequently, the histology labels indicate the animal groups and
not the actual times of death postirradiation.
Statistical Analyses
Error bars on graphs (and the percentage errors reported in the text)
represent the percentage error of the mean value calculated as the sum,
added in quadrature, of the standard deviation for the preirradiation
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measurements expressed as a percentage relative to the mean
preirradiation value (i.e. unity) and that of the measurement at 2, 4,
8, 12 or 24 h postirradiation.
In practice, our experience in a control population (5) has been that
intra-subject variation is less than that of inter-subject variation, thus
making test–retest comparisons, with the animal as its own control,
more sensitive to physiological changes than grouped comparisons of
the set of animals before irradiation, compared to postirradiation. To
make the effect of an intervention easily understood, it has been our
usual practice to express test–retest differences as percentage changes.
This is a practice that will be followed herein.
Vascular measurements at the time points after irradiation were
compared with preirradiation values from the same rats, computed as
percentage differences. Significant percentage differences were
determined using the Wilcoxon signed-rank test. The null hypothesis
was that there was no likelihood of finding a preponderance of
percentage differences in one direction. Differences of P  0.05 were
considered statistically significant.
In a sample of 17 control animals tested previously (5), but without
a therapeutic intervention, it was found that paired differences in vp,
Ktrans and ve had standard errors of the mean that were on the order of
3–4% of the sample mean value. Thus, in a sample of 4–5 animals
treated with an intervening therapeutic intervention, it should be
expected that paired differences in parameters of more than about
620% demonstrate a significant effect of the intervention.
Representative blood flow distribution parameters are presented in
Supplementary Table S1 (http://dx.doi.org/10.1667/RR134581.S1),
including upper value, lower value, range, median, mean, variance,
skewness and kurtosis. Similar values characterizing the distributions
of Ktrans and ve are presented in Supplementary Table S2 (http://dx.doi.
org/10.1667/RR134581.S1).
RESULTS
In 25 animals prior to irradiation, tumor blood flow was
characterized by arterial spin labeling as follows: mean 6
SEM¼ 83.1 6 7.0 ml/100g min and median 83.2 ml/100g
min. The DCE-MRI vascular parameters in tumor prior to
radiation exposure were (mean 6 SEM and median): vp ¼
1.18 6 0.12% and 1.09%; Ktrans ¼ (4.01 6 0.21) 3 102
min1 and 4.06 3 102 min1; ve ¼ 13.74 6 0.70% and
13.50%. Blood flow across animals was normally distrib-
uted prior to irradiation (Supplementary Tables S1 and S2;
http://dx.doi.org/10.1667/RR134581.S1) with mean values
similar to those previously reported (6, 11, 18).
Figure 2A shows that 2 h after 20 Gy irradiation, tumor
blood flow exhibited a marked initial decrease to between
70 and 80% of preirradiation levels. Blood flow values at 2
and 4 h after 20 Gy irradiation were significantly below
preirradiation values (P , 0.05), followed by a return to
preirradiation values over the subsequent 8 h. At 8 and 12 h
postirradiation, tumor blood flow was on average not
significantly different from preirradiated levels. Subsequent-
ly, tumor blood flow increased. At 24 h postirradiation,
tumor blood flow exceeded preirradiation levels, on
average, by 40% (P , 0.05).
Parameters of representative blood flow distributions are
shown in Table 1. The blood flow patterns within individual
animals were normally distributed even at low blood flow
values (see, for example, the 2 h time point after 20 Gy), the
mean values were similar to the median values and both the
skewness and kurtosis were usually small.
The kinetics of other vascular parameters are shown in
Fig. 2B. The mean of the forward volume transfer constant,
Ktrans, in the tumor region of interest demonstrated a bimodal
response, increasing at 4 h to 35% above preirradiated
values (P , 0.05) and declining at 12 and 24 h
postirradiation. At 24 h, Ktrans values were 20–40% below
the preirradiation level (P , 0.05).
The mean ve was below preirradiation values throughout
the study, pointing to a significant loss of interstitial volume
fraction. At 2 h after irradiation, ve was 30% below
preirradiated values (2 h ve, P , 0.05). ve temporarily
approached preirradiated values 4 h after irradiation, but
subsequently decreased to 30% below preirradiated levels at
24 h postirradiation (24 h ve, P , 0.05).
Over the 24 h period after irradiation, plasma volume, vp,
was unchanged. In fact, vp fluctuated above and below
FIG. 2. Changes in MRI-measured vascular parameters after 20 Gy.
Panel A: Tumor blood flow changes as a function of time after 20 Gy
irradiation. Error bars reflect combined errors of both pre- and
postirradiation values. Pre- and postirradiation values at 2, 4 and 24 h
were significantly different as indicated by the asterisks (*). Panel B:
Fractional changes in vascular measures after 20 Gy irradiation
including forward volume transfer constant, Ktrans and interstitial
volume fraction, ve. Error bars reflect combined errors of both pre- and
postirradiation values. Graph symbols without error bars had error
bars smaller than the symbol. Pre- and postirradiation values at 4 and
24 h were significantly different for Ktrans and for ve at 2 and 24 h as
indicated by the asterisk (*).
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preirradiated values. However, the associated error bars
were large and the trends unremarkable over the 24 h period
(data not shown).
Compared to the large and significant vascular changes
observed after 20 Gy irradiation in brain tumors, observed
changes in blood flow were smaller in normal rat brains (n¼
4) after 20 Gy irradiation. Normal brain blood flow at 2 h
after 20 Gy irradiation decreased by 23 6 5% compared
with preirradiation values. Similarly, at 24 h blood flow was
somewhat elevated above the preirradiation value by 15 6
27%, but not significantly different from preirradiation
levels. The blood flow changes in the normal brain after 20
Gy did not differ using either the 6 mm secondary
collimator cone or the 1 3 1 cm field size. Consequently,
the changes in the normal brain blood flow after 20 Gy
irradiation were judged to be unremarkable.
Interestingly, 2 h after 6 Gy irradiation within the region
of interest of the tumor, there was little evidence of change
in blood flow compared with preirradiation blood flow
values. However, at 24 h blood flow appeared to be
increased by 30 6 6% compared with preirradiation blood
flow values. These findings should be weighted by the small
sample size, and further investigation in the normal brain as
well as other tumor types should be conducted.
The acute vascular changes observed in the tumor after 20
Gy irradiation coincided with profound histological changes
within the tumor. Examination of brain sections demon-
strated gross injury within the tumor even at the earliest time
point after 20 Gy irradiation. Figure 3 shows the contrast
between irradiated and nonirradiated rat brains and is
representative of all animals in the group. Regions of the
tumor exhibit vacuoles and rounded nuclei and occasionally
double nucleoli.
To determine if the vascular changes observed were
accompanied by changes in cellular apoptosis, brain
sections underwent TUNEL assay. Figure 4 shows large
regions of the tumor characterized by an increase in
apoptosis at the earliest time point after 20 Gy irradiation,
whereas nonirradiated, control brain showed minimal levels
of apoptosis. Some, but not the majority, of cells staining
positive for apoptosis were endothelial cells.
DISCUSSION
To the best of our knowledge, this is the first report of a
differential effect of high-dose radiotherapy on the acute
vascular response of tumor and normal tissue. In an
orthotopic tumor model, tumor blood flow was found to
decrease after high-dose irradiation, remained low for
several hours, but ultimately exceeded baseline values after
24 h. Normal brain blood flow was relatively unaffected
during this timeframe after a high-dose radiation exposure.
Others have reported tumor blood flow changes after
irradiation using subcutaneously implanted tumors (19–21),
including an acute decrease in tumor blood flow (i.e.
ischemia) followed by an increase (i.e. hyperemia).
However, the potential significance of acute changes in
vascular physiology for additional cell killing in tumor, but
not in normal tissue has not been previously recognized. In
particular, to our knowledge this is the first report in which:
1. The decrease in tumor blood flow observed at 2 h after 20
Gy irradiation was significantly different from normal brain;
and 2. Unlike the overshoot in the blood flow of the tumor
at 24 h postirradiation, there was no such overshoot in the
normal brain. Furthermore, unlike that observed after 20 Gy
irradiation, the differential in blood flow between tumor and
normal brain after the lower 6 Gy radiation dose was not
observed, although we caution that the sample size was
small.
The mechanism that causes acute blood flow in the tumor
after irradiation to differ from that of normal tissue is not yet
fully understood, although it appears that cell swelling and
flow are at least covariant. Nevertheless, this physiological
FIG. 3. Representative control (four left-side panels) and high-dose irradiated (four right-side panels) H&E
stained brain sections. Right-side panels: Histology taken from a tumor in which the MRI started at 2 h after
high-dose (20 Gy) irradiation shows prevalence of vacuolizations. Left-side panels: Conversely, vacuolizations
are not prevalent in a nonirradiated tumor. Neither vacuolization nor other gross tissue injury was observed in the
irradiated normal brain.
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change is not without its consequences; striking differences
between normal parenchyma and tumor have been observed
histologically (Fig. 3). Tumor tissue vacuolization was
easily observed, even hours after a 20 Gy radiation
exposure, whereas the normal brain was histologically
unremarkable. As noted, coinciding with a decrease in
tumor blood flow, a significant decrease in interstitial
volume fraction determined by DCE-MRI was observed.
Cellular swelling was not measurable in the normal brain,
and such measures using DCE-MRI may not be possible,
since they require extravasation of contrast agent. Never-
theless, there is no histological evidence that swelling in the
normal brain occurred.
A decrease in interstitial volume fraction suggests that
cellular swelling occurs in tumors and not normal tissue
almost immediately (hours) after high-dose irradiation.
Cellular swelling may result from apoptosis (22), a process
characterized by nuclear pyknosis, and could cause an acute
reduction in blood flow by compression of cerebral
microvessels. Indeed, ceramide-dependent apoptosis has
been proposed after high-dose irradiation (23). Ceramide-
dependent apoptosis has been shown to govern endothelial
cell survival after irradiation, although it is of note that the
same investigators show the effect to be present in both
tumor (23) and normal tissue (24). Likewise, Park et al.
proposed that vascular changes lead to tumor response (4).
However, their rationale is that prolonged hypoxia causes
cell death. Again, their explanations offer no reason for a
differential effect between tumor and normal tissue. Finally,
arguments put forth to explain radiation injury based on
immunological response to high-dose exposures (25–27) do
not consider differences between tumor and normal tissue.
The data shown in this article represent the first report of a
differential tumor/normal tissue biological effect observed
hours after high-dose irradiation.
The cause of the dramatic early damage to the tumor,
observed in tumor histological sections, is not known,
although there is certainly a high level of DNA fragmen-
tation characteristic of apoptosis in the U-251 tumor soon
after high-dose irradiation, as shown in Fig. 4. The transient
relative increase in Ktrans 4 h after a large dose of radiation
(Fig. 2) is consistent with damage to tumor vasculature and
is not a new observation. A transient increase in vascular
permeability after a large dose of radiation was previously
demonstrated qualitatively in subcutaneously transplanted
tumors grown in the feet of mice (28). As discussed, in the
model presented herein, the change in Ktrans was preceded 2
h earlier by a decrease in interstitial volume fraction. The
effect of 20 Gy irradiation on interstitial volume fraction
was significant and immediate, remaining below preirra-
diation values for at least 24 h. The initial large decrease in
ve suggests an immediate postirradiation cellular swelling.
As noted, this phenomenon might be consistent with the
hypothesis that endothelial cells undergo apoptotic death
FIG. 4. Signs of apoptosis in the hours after irradiation. Left-side panels show nonirradiated tumor and right-
side panels show irradiated tumor. A higher level of DNA fragmentation is evident in the tumor in the hours after
20 Gy irradiation. The left-side panels show low background staining and sparse apoptotic bodies detected by
DNA fragmentation using the terminal end of nucleic acids, so-called terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay. The right-side panels show both a higher level of DNA fragmentation
throughout the irradiated tumor soon after exposure to 20 Gy, as well as more apoptotic bodies. The rat
represented in the right-side panels was imaged 2 h after irradiation and euthanized within 1–2 h thereafter.
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after single high-dose radiation exposure (4) or perhaps
more likely, cancer cells throughout the tumor undergo this
process. The latter scenario of overall cellular swelling due
to tumor cell apoptosis in the first hours after radiation
exposure is consistent with this observation, since such
swelling might be expected to compress the vascular supply
of the tumor, thus reducing blood flow. As interstitial
volume fraction returned toward preirradiation levels,
presumably due to resolution of cellular swelling, and
vascular permeability decreased, thus probably decreasing
tumor interstitial pressure, tumor blood flow also improved.
We observed increased blood flow coincident with an initial
increase in forward volume transfer constant, Ktrans, as
expected since Ktrans is the product of flow and extraction
fraction. In this model of an embedded cerebral tumor,
plasma volume trends were unremarkable, characterized by
large errors and remaining relatively unchanged throughout
the 24 h measurement period. At about 8 h postirradiation,
all vascular parameters, including blood flow, approached
preirradiation values. However, by 24 h postirradiation, the
blood flow had overshot preirradiation values by 40%.
Other vascular parameters, i.e., Ktrans and ve were decreased
by 20–30%.
The exposure time used in the current study is shorter
than that typically used for radiosurgery in humans. Further
study is needed to understand the importance of total dose,
dose rate and exposure time. Decreased blood flow
developing over the time of a more protracted exposure
time could have implications for tumor response.
The pattern of profound decrease in tumor blood flow,
followed by a robust overshoot, suggests that an ischemia-
reperfusion mechanism (29–32) may be a factor in the
overall efficacy of high-dose radiation in the treatment of
embedded tumors. Despite an extensive knowledge base in
a number of human pathologies, including heart attacks and
stroke, there is a dearth of recent studies in ischemia-
reperfusion in tumors. Parkins and colleagues, in a series of
articles, documented the effects of ischemia-reperfusion in
solid tumors (29–32). Animal tumors were temporarily
clamped physically to show that little or no cell kill was
detectable in tumors exposed to up to 3 h of ischemia when
tumors were excised immediately before reperfusion.
However, when reperfusion was permitted, extensive cell
kill was evident 24 h later. The investigators attributed
damage to oxygen radicals, because intravenous adminis-
tration of superoxide dismutase or catalase, at the time when
vascular reperfusion occurred, resulted in significant
protection against tumor cell kill (29). Because these
experiments involved only ischemia, the combined effect
of radiation exposure and ischemia-reperfusion could not be
described, and remains to be examined in depth, now that a
technique for noninvasively estimating acute changes in
tumor physiology is available.
Since the mid-1980s it has been established that oxygen-
derived free radicals hold a major role in post-ischemic
tissue injury (33). During ischemia native xanthine
dehydrogenase is converted to superoxide-producing xan-
thine oxidase by a calcium-triggered, protease-dependent
process. Also during ischemia, ATP is degraded; a
breakdown product of adenine is hypoxanthine. Conse-
quently, the catabolic degradation of ATP during ischemia
provides an oxidizable substrate, hypoxanthine. On reper-
fusion, molecular oxygen is resupplied and a burst of
superoxide production ensues, resulting in extensive tissue
damage. We hypothesize, based on radiation-induced acute
changes in tumor blood flow that a similar mechanism
occurs in solid tumors after high-dose irradiation. If this is
true, xanthine dehydrogenase is rapidly converted to the
oxidase during the period of nonperfusion in the tumor
shortly after it is irradiated at a high dose. Superoxide is not
particularly reactive by itself, but undergoes multiple
reactions into unstable and highly toxic reactive oxygen
species and reactive nitrogen species (ROS/RNS). The
production of ROS/RNS after ischemia-reperfusion is
shown schematically in Fig. 5.
In addition, other mechanisms may be at work. For
example, SDF-1, a major antigen for leukocytes and
macrophages, is known to be expressed in tumors and
increases its expression after hypoxia (34, 35). Leukocytes
and macrophages are known to produce damaging ROS/
RNS, however, this is a relatively unexplored pathway in
the context of ischemia-reperfusion.
In summary, measures of acute changes in tumor
physiology may help explain the remarkable clinical tumor
responses to high-dose radiation. Hypofractionated stereo-
tactic radiotherapy is generally delivered using doses per
fraction varying between 5 and 9 Gy, substantially higher
than the doses per fraction of 1.8–2.0 Gy commonly used
with conventional fractionated radiation therapy. It is
unknown if these doses are high enough to produce
vascular changes in a pattern similar to that observed in
the current study. As mentioned, several other processes
may be at work. First, it has been suggested that tumor
vasculature is sensitive to radiation above a threshold dose
due to a ceramide-dependent apoptosis of endothelial cells
(23). Second, Song and colleagues have long studied the
effects of radiation exposure on tumor blood flow, and
believe that high-dose radiation causes prolonged ischemia
that leads to additional cell killing, which otherwise would
not occur (4). Third, Demaria and colleagues and McBride
and colleagues have implicated the immune system in the
tumor response to high-dose radiation (27). Of note, all of
these postulates share the same limitation that they do not
explain the differential effect of high-dose radiation on the
tumor and surrounding normal tissue.
Further studies are needed to examine the effect of single
high doses of radiation. Tumor vascular dynamics should be
considered in the context that changes in blood flow after
radiation exposure depend on dose, dose rate, tumor
volume, tumor type, microenvironment and immune
response. Measurements of tumor oxygenation have been
reported in other animal models (36, 37) and would be
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important to repeat in an orthotopic brain tumor model
hours after irradiation. Vascular changes that are reported in
the first 24 h postirradiation may have utility for
understanding the acute response of tumors to radiotherapy
alone, as well as when radiation is combined with vascular
targeting agents, antiangiogenic agents and other treatment
modalities.
SUPPLEMENTARY INFORMATION
Table S1. Representative blood flow distributions.
Table S2. DCE-MRI vascular parameter distributions.
Fig. S1. Example of a radiation treatment plan.
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